多抗甲素系多糖类物质,毒性小且有增强机体免疫功能的作用。作者于1982年2月首先试用于治疗再生障碍性贫血,先后观察11例,其中男性7例,女性4例,年龄在15～67岁之间,年龄15～35岁8例占72.73％。药物为四川抗菌素工业研究所、成都军区制药一厂生产的每安瓿5毫克多抗甲素,批号820602和831209。9例按照Fibonacci调正剂量公式递增方法给药。1例开始用原液作皮内试验20分钟无反应,即将剩余的药物作肌肉注射,其余8例采用2.5mg肌 Multi-anti-A-polysaccharide substances, small toxicity and enhance the body’s immune function. The author first trial in February 1982 for the treatment of aplastic anemia, has observed 11 cases, including 7 males and 4 females, aged 15 to 67 years old, aged 15 to 35 years, 8 cases accounted for 72.73%. Drugs for the Sichuan Institute of Antibiotics, Chengdu Military Region Pharmaceutical Factory 1 ampoules produced per mg 5 mg, lot number 820602 and 831209.9 cases in accordance with the Fibonacci dose adjustment formula for administration. 1 patient began to use the solution for intradermal test 20 minutes no response, the remaining drugs for intramuscular injection, and the remaining 8 cases with 2.5mg muscle